Tactile Systems Technology Inc (TCMD)
13.66
-0.03
(-0.22%)
USD |
NASDAQ |
May 16, 16:00
13.68
+0.02
(+0.15%)
After-Hours: 20:00
Tactile Systems Technology Enterprise Value: 277.95M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 16, 2024 | 277.95M |
May 15, 2024 | 278.67M |
May 14, 2024 | 277.24M |
May 13, 2024 | 281.99M |
May 10, 2024 | 283.66M |
May 09, 2024 | 287.22M |
May 08, 2024 | 282.47M |
May 07, 2024 | 296.49M |
May 06, 2024 | 290.55M |
May 03, 2024 | 292.57M |
May 02, 2024 | 296.49M |
May 01, 2024 | 294.11M |
April 30, 2024 | 280.56M |
April 29, 2024 | 289.12M |
April 26, 2024 | 293.16M |
April 25, 2024 | 292.45M |
April 24, 2024 | 310.74M |
April 23, 2024 | 299.57M |
April 22, 2024 | 301.47M |
April 19, 2024 | 295.53M |
April 18, 2024 | 289.36M |
April 17, 2024 | 289.83M |
April 16, 2024 | 295.06M |
April 15, 2024 | 288.41M |
April 12, 2024 | 304.56M |
Date | Value |
---|---|
April 11, 2024 | 310.98M |
April 10, 2024 | 310.74M |
April 09, 2024 | 323.57M |
April 08, 2024 | 323.57M |
April 05, 2024 | 328.80M |
April 04, 2024 | 315.73M |
April 03, 2024 | 319.06M |
April 02, 2024 | 313.59M |
April 01, 2024 | 325.71M |
March 31, 2024 | 339.49M |
March 28, 2024 | 340.00M |
March 27, 2024 | 330.73M |
March 26, 2024 | 321.23M |
March 25, 2024 | 334.06M |
March 22, 2024 | 344.51M |
March 21, 2024 | 346.41M |
March 20, 2024 | 344.51M |
March 19, 2024 | 336.91M |
March 18, 2024 | 330.14M |
March 15, 2024 | 351.88M |
March 14, 2024 | 341.42M |
March 13, 2024 | 336.43M |
March 12, 2024 | 329.86M |
March 11, 2024 | 327.50M |
March 08, 2024 | 325.38M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
145.69M
Minimum
Jul 12 2022
1.298B
Maximum
Dec 24 2019
595.54M
Average
562.48M
Median
Enterprise Value Benchmarks
Glaukos Corp | 5.571B |
Shockwave Medical Inc | 12.13B |
RxSight Inc | 2.190B |
Perspective Therapeutics Inc | 890.47M |
Xtant Medical Holdings Inc | 106.24M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.209M |
Revenue (Quarterly) | 61.09M |
Total Expenses (Quarterly) | 64.05M |
EPS Diluted (Quarterly) | -0.09 |
Gross Profit Margin (Quarterly) | 71.09% |
Profit Margin (Quarterly) | -3.62% |
Earnings Yield | 8.75% |
Operating Earnings Yield | 5.07% |
Normalized Earnings Yield | 8.008 |